Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEXTROSE\HEPARIN Cause Hypophosphataemia? 27 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Hypophosphataemia have been filed in association with DEXTROSE\HEPARIN. This represents 24.6% of all adverse event reports for DEXTROSE\HEPARIN.

27
Reports of Hypophosphataemia with DEXTROSE\HEPARIN
24.6%
of all DEXTROSE\HEPARIN reports
27
Deaths
24
Hospitalizations

How Dangerous Is Hypophosphataemia From DEXTROSE\HEPARIN?

Of the 27 reports, 27 (100.0%) resulted in death, 24 (88.9%) required hospitalization, and 23 (85.2%) were considered life-threatening.

Is Hypophosphataemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEXTROSE\HEPARIN. However, 27 reports have been filed with the FAERS database.

What Other Side Effects Does DEXTROSE\HEPARIN Cause?

General physical health deterioration (61) Hyponatraemia (61) Multiple organ dysfunction syndrome (61) Stress (61) Appendicitis (60) Ascites (60) Cardiogenic shock (60) Sepsis (60) Ventricular fibrillation (60) Appendicolith (59)

What Other Drugs Cause Hypophosphataemia?

FERRIC CARBOXYMALTOSE (1,046) ADEFOVIR DIPIVOXIL (368) DENOSUMAB (322) ZOLEDRONIC ACID (235) LAMIVUDINE (205) CYCLOPHOSPHAMIDE (196) TENOFOVIR DISOPROXIL (192) DEXAMETHASONE (186) ACETAMINOPHEN (169) LANSOPRAZOLE (159)

Which DEXTROSE\HEPARIN Alternatives Have Lower Hypophosphataemia Risk?

DEXTROSE\HEPARIN vs DEXTROSE\LIDOCAINE DEXTROSE\HEPARIN vs DEXTROSE\SODIUM DEXTROSE\HEPARIN vs DIACETYLMORPHINE DEXTROSE\HEPARIN vs DIAMORPHINE DEXTROSE\HEPARIN vs DIANEAL LOW

Related Pages

DEXTROSE\HEPARIN Full Profile All Hypophosphataemia Reports All Drugs Causing Hypophosphataemia DEXTROSE\HEPARIN Demographics